MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The relationship between dimensions of mental health and markers of Parkinson’s disease risk in the UK Biobank

    B. Attaallah, S. Waters, C. Marshall, A. Noyce (London, United Kingdom)

  • The relationship between pain threshold and striatal dopamine function in Parkinson’s Disease

    H. Kawasaki, Y. Sakasai, S. Fujita, R. Yokoyama, K. Seo, Y. Ito, T. Yamamoto (moroyama, Japan)

  • The Role of a Social Worker in a Deep Brain Stimulation Multidisciplinary Team

    A. Currie, R. Burke, A. Martinez Nunez, A. Mckay, M. Okun (Gainesville, USA)

  • The role of cognitive functions on the outcomes of an intensive multidisciplinary rehabilitation program for people with Parkinson’s disease

    L. Ricciardi, P. Ortelli, MC. Campo, D. Ferrazzoli, F. Morgante, J. Goldman, D. Volpe (London, United Kingdom)

  • The Role of Cortisol a Mediator in Influencing Cognitive Function

    DT. Akramova (Tashkent, Uzbekistan)

  • The role of extracellular vesicles in the progression of Parkinson’s disease

    T. Tsunemi, Y. Ishiguro, A. Yoroisaka, T. Shimada, F. Feng, W. Akamatsu, N. Hattori (Tokyo, Japan)

  • The role of LRRK2 in regulating microglial activity in Parkinson’s disease

    S. Brooker, A. Thomas, D. Krainc (Chicago, USA)

  • the role of metabotropic glutamate receptors type 3 and 5 in parkinson’s disease: analysis of grm3 and grm5 genbe variants.

    M. Alborghetti, E. Bianchini, D. Rinaldi, I. de Bartolo, L. Di Menna, G. Battaglia, V. Bruno, T. Esposito, M. Borro, M. Simmaco, F. Pontieri, A. Berardelli, F. Nicoletti (Rome, Italy)

  • The role of pathology validation on the association between smoking and Parkinson’s Disease

    P. Pecoraro, S. Carbone, F. Alessi, V. Di Lazzaro, L. Di Biase (Rome, Italy)

  • the role of the “unfolded protein response” and the perk pathway in parkinson’s disease: study of genetic polymorphisms

    N. Palomba, E. Bianchini, D. Rinaldi, C. Strafella, V. Caputo, F. Garramone, P. Lombardo, F. Nicoletti, E. Giardina, T. Esposito, F. Pontieri, M. Alborghetti ()

  • « Previous Page
  • 1
  • …
  • 164
  • 165
  • 166
  • 167
  • 168
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley